{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T22:16:39Z","timestamp":1648937799438},"reference-count":10,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.neurol.2017.03.027","type":"journal-article","created":{"date-parts":[[2017,4,28]],"date-time":"2017-04-28T23:46:44Z","timestamp":1493423204000},"page":"418-420","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Topiramate response in adult-onset opsoclonus\u2013myoclonus\u2013ataxia syndrome: A case report"],"prefix":"10.1016","volume":"173","author":[{"given":"Y.","family":"Degirmenci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Kececi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.neurol.2017.03.027_bib0055","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/MOP.0b013e32833fde3f","article-title":"Update on diagnosis, treatment, and prognosis in opsoclonus-myoclonus-ataxia syndrome","volume":"22","author":"Gorman","year":"2010","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.neurol.2017.03.027_bib0060","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/B978-0-444-52910-7.00042-8","article-title":"Opsoclonus-myoclonus syndrome","volume":"112","author":"Pike","year":"2013","journal-title":"Handb Clin Neurol"},{"issue":"4","key":"10.1016\/j.neurol.2017.03.027_bib0065","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1001\/jamaneurol.2015.4757","article-title":"New findings in adult opsoclonus-myoclonus syndrome","volume":"73","author":"Honnorat","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neurol.2017.03.027_bib0070","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/WCO.0b013e3280126b51","article-title":"An update on opsoclonus","volume":"20","author":"Wong","year":"2007","journal-title":"Curr Opin Neurol"},{"issue":"3","key":"10.1016\/j.neurol.2017.03.027_bib0075","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.braindev.2015.09.002","article-title":"Rituximab treatment for relapsed opsoclonus-myoclonus syndrome","volume":"38","author":"Toyoshima","year":"2016","journal-title":"Brain Dev"},{"issue":"1","key":"10.1016\/j.neurol.2017.03.027_bib0080","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1001\/archneurol.2011.717","article-title":"Topiramate effect in opsoclonus-myoclonus-ataxia syndrome","volume":"69","author":"Fernandes","year":"2012","journal-title":"Arch Neurol"},{"issue":"3","key":"10.1016\/j.neurol.2017.03.027_bib0085","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1136\/jnnp.25.3.271","article-title":"Myoclonic encephalopathy of infants","volume":"25","author":"Kinsbourne","year":"1962","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.neurol.2017.03.027_bib0090","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1136\/practneurol-2011-000017","article-title":"The opsoclonus\u2013myoclonus syndrome","volume":"11","author":"Sahu","year":"2011","journal-title":"Pract Neurol"},{"key":"10.1016\/j.neurol.2017.03.027_bib0095","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jneuroim.2009.03.006","article-title":"Elevated B-cell activating factor BAFF, but not APRIL, correlates with CSF cerebellar autoantibodies in pediatric opsoclonus-myoclonus syndrome","volume":"210","author":"F\u00fchlhuber","year":"2009","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neurol.2017.03.027_bib0100","first-page":"1209","article-title":"Pediatric neurology Part II","volume":"112","author":"Dulac","year":"2013"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378716302326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378716302326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T07:50:46Z","timestamp":1535874646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378716302326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0035378716302326"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2017.03.027","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topiramate response in adult-onset opsoclonus\u2013myoclonus\u2013ataxia syndrome: A case report","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2017.03.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}